The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
T. Rowe Price International Eq Index PIEQX
- NAV / 1-Day Return 17.39 / +0.52 %
- Total Assets 805.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.260%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 2.66%
- Turnover 29%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis PIEQX
Will PIEQX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Msci Eafe Fut 9/24 | 3.23 | 34.8 Mil | — |
Trp Government Reserve | 2.61 | 28.1 Mil | Cash and Equivalents |
Novo Nordisk AS Class B | 2.50 | 26.9 Mil | Healthcare |
ASML Holding NV | 1.99 | 21.4 Mil | Technology |
Nestle SA | 1.58 | 17.0 Mil | Consumer Defensive |
AstraZeneca PLC | 1.50 | 16.2 Mil | Healthcare |
Roche Holding AG | 1.32 | 14.2 Mil | Healthcare |
Novartis AG Registered Shares | 1.31 | 14.1 Mil | Healthcare |
SAP SE | 1.27 | 13.7 Mil | Technology |
Shell PLC | 1.24 | 13.4 Mil | Energy |